EMEA Recommends Stronger Depression Language In Acomplia Label
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency is seeking to include a contraindication in people with depression or who are being treated with antidepressants.
You may also be interested in...
Sanofi Withdraws Zimulti NDA For Weight Loss
Company cites confusion over concerns raised by the Endocrinologic and Metabolic Drugs Advisory Committee, which voted against approval June 13.
Acomplia To Launch In July In Europe For Obesity Indication
Sanofi-Aventis’ rimonabant is currently “approvable” at FDA for obesity.
Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.